Tocol Pharmaceuticals LLC is categorized under Wholesale Pharmaceutical Products in Little Rock, AR and active since 2010.
Tocol Pharmaceuticals LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Philip Breen at the company’s single location by writing to 94 Woodlore Circle, Little Rock, Arkansas AR 72211 or by phoning (501) 227-7684. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tocol Pharmaceuticals LLC |
| Contact Person: | Philip Breen |
| Address: | 94 Woodlore Circle, Little Rock, Arkansas 72211 |
| Phone Number: | (501) 227-7684 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Tocol Pharmaceuticals LLC was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Philip Breen for inquiries that concern Tocol Pharmaceuticals LLC by calling the company number (501) 227-7684, as your correspondence is most welcome. Additionally, the physical location of the single location of Tocol Pharmaceuticals LLC can be found at the coordinates 34.760222,-92.406825 as well as the street address 94 Woodlore Circle in Little Rock, Arkansas 72211.
For its online presence, you may visit Tocol Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.